Hint mode is switched on Switch off
For swift navigation between sections

Oxurion
LEI 549300VWY8KVDFKLDM59

PDF download

Choose all Reset all
Download Cancel
Organization name
Oxurion NV
Country name
Belgium
Country of registration
Belgium
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines that address unmet clinical needs in ophthalmology in Belgium and internationally.

Awards

News

19/03/2025 Oxurion to Acquire Majority Stake in Contract Research Organization
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300VWY8KVDFKLDM59
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • Numero d’entreprise / Ondernemingsnummer
    0881620924
Registration is required to get access.